We were thrilled to host a Lhasa Limited Symposium in Shanghai, China, alongside CloudScientific.
On 17th October 2024, we brought together professionals from industry to address critical topics on on impurity assessment and control in drug development and manufacturing.
The event offered valuable insights from experts on ICH M7 assessment, process and degradation impurities, and the application of innovative in silico tools – helping attendees to better understand relevant regulations, and apply the latest technologies for impurity control.
External guest speakers included:
- Jack Lin, CEO, CloudScientific
- Peng She, Director of R&D Analysis, Small Molecule Division, Porton Pharma Solutions
- Dr Mike Urquhart, Scientific Director, Drug Substance Development, GSK
- Dr Lirong Cai, Engineer of Pharmaceutical Excipients Key Laboratory, Hunan Institute
- Luccas Sanches, Researcher, Spektra Consulting
Symposium topics included:
- ICH M7 Assessments
- Elemental Impurities in Drug Products
- Process and Degradation Impurities